Recursion Pharmaceuticals Inc - Ordinary Shares - Class A
RXRX
Market Cap$2.17B
Close$
Share Statistics
| Market cap | $2.17 Billion |
|---|---|
| Enterprise Value | $1.92 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.62 |
| Beta | 0.0 |
| Outstanding Shares | 230,273,797 |
| Avg 30 Day Volume | 5,339,196 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -6.13 |
|---|---|
| PEG | -15.36 |
| Price to Sales | - |
| Price to Book Ratio | 9.42 |
| Enterprise Value to Revenue | 41.61 |
| Enterprise Value to EBIT | -5.11 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.13 |
Revenue Sources
No data
ESG Score
No data
About Recursion Pharmaceuticals Inc
218 employeesRecursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patient...